In trading on Monday, shares of BioCryst Pharmaceuticals, Inc. (BCRX - Get Report) crossed below their 200 day moving average of $7.66, changing hands as low as $7.58 per share. BioCryst Pharmaceuticals, Inc. shares are currently trading down about 3.5% on the day. The chart below shows the one year performance of BCRX shares, versus its 200 day moving average:Looking at the chart above, BCRX's low point in its 52 week range is $1.42 per share, with $13.33 as the 52 week high point — that compares with a last trade of $7.73. According to the ETF Finder at ETF Channel, BCRX makes up 1.06% of the SPDR S&P Biotech ETF ( XBI) which is trading lower by about 0.7% on the day Monday.
More from Stocks
McDonalds Misses Q3 Earnings Forecast as US Same-Store Sales Slow; Shares Slide
McDonald's reported weaker-than-expected third quarter earnings Tuesday and noted moderately disappointing comparable sales in its domestic U.S. business.
Nasdaq Will Benefit From New Way of Measuring the U.S. Economy
While GDP measures the value of goods and services bought and sold, many of the products central to modern life are not bought and sold at all.
Dow Futures Higher Amid Q3 Earnings Wave; US-China Trade Hopes Boost Sentiment
Global stocks edged higher Tuesday, helping lift Wall Street futures into the green, as investors focused on a wave of corporate earnings on both sides of the Atlantic that temporarily snuffed out optimistic signals from both sides of the U.S.-China trade dispute.